Tag Archives: Wendel Wohlleben

Sustainable Nanotechnologies (SUN) project draws to a close in March 2017

Two Oct. 31, 2016 news item on Nanowerk signal the impending sunset date for the European Union’s Sustainable Nanotechnologies (SUN) project. The first Oct. 31, 2016 news item on Nanowerk describes the projects latest achievements,

The results from the 3rd SUN annual meeting showed great advancement of the project. The meeting was held in Edinburgh, Scotland, UK on 4-5 October 2016 where the project partners presented the results obtained during the second reporting period of the project.

SUN is a three and a half year EU project, running from 2013 to 2017, with a budget of about €14 million. Its main goal is to evaluate the risks along the supply chain of engineered nanomaterials and incorporate the results into tools and guidelines for sustainable manufacturing.

The ultimate goal of the SUN Project is the development of an online software Decision Support System – SUNDS – aimed at estimating and managing occupational, consumer, environmental and public health risks from nanomaterials in real industrial products along their lifecycles. The SUNDS beta prototype has been released last October, 2015, and since then the main focus has been on refining the methodologies and testing them on selected case studies i.e. nano-copper oxide based wood preserving paint and nano- sized colourants for plastic car part: organic pigment and carbon black. Obtained results and open issues were discussed during the third annual meeting in order collect feedbacks from the consortium that will inform, in the next months, the implementation of the final version of the SUNDS software system, due by March 2017.

An Oct. 27, 2016 SUN project press release, which originated the news item, adds more information,

Significant interest has been payed towards the results obtained in WP2 (Lifecycle Thinking) which main objectives are to assess the environmental impacts arising from each life cycle stage of the SUN case studies (i.e. Nano-WC-Cobalt (Tungsten Carbide-cobalt) sintered ceramics, Nanocopper wood preservatives, Carbon Nano Tube (CNT) in plastics, Silicon Dioxide (SiO2) as food additive, Nano-Titanium Dioxide (TiO2) air filter system, Organic pigment in plastics and Nanosilver (Ag) in textiles), and compare them to conventional products with similar uses and functionality, in order to develop and validate criteria and guiding principles for green nano-manufacturing. Specifically, the consortium partner COLOROBBIA CONSULTING S.r.l. expressed its willingness to exploit the results obtained from the life cycle assessment analysis related to nanoTiO2 in their industrial applications.

On 6th October [2016], the discussions about the SUNDS advancement continued during a Stakeholder Workshop, where representatives from industry, regulatory and insurance sectors shared their feedback on the use of the decision support system. The recommendations collected during the workshop will be used for the further refinement and implemented in the final version of the software which will be released by March 2017.

The second Oct. 31, 2016 news item on Nanowerk led me to this Oct. 27, 2016 SUN project press release about the activities in the upcoming final months,

The project has designed its final events to serve as an effective platform to communicate the main results achieved in its course within the Nanosafety community and bridge them to a wider audience addressing the emerging risks of Key Enabling Technologies (KETs).

The series of events include the New Tools and Approaches for Nanomaterial Safety Assessment: A joint conference organized by NANOSOLUTIONS, SUN, NanoMILE, GUIDEnano and eNanoMapper to be held on 7 – 9 February 2017 in Malaga, Spain, the SUN-CaLIBRAte Stakeholders workshop to be held on 28 February – 1 March 2017 in Venice, Italy and the SRA Policy Forum: Risk Governance for Key Enabling Technologies to be held on 1- 3 March in Venice, Italy.

Jointly organized by the Society for Risk Analysis (SRA) and the SUN Project, the SRA Policy Forum will address current efforts put towards refining the risk governance of emerging technologies through the integration of traditional risk analytic tools alongside considerations of social and economic concerns. The parallel sessions will be organized in 4 tracks:  Risk analysis of engineered nanomaterials along product lifecycle, Risks and benefits of emerging technologies used in medical applications, Challenges of governing SynBio and Biotech, and Methods and tools for risk governance.

The SRA Policy Forum has announced its speakers and preliminary Programme. Confirmed speakers include:

  • Keld Alstrup Jensen (National Research Centre for the Working Environment, Denmark)
  • Elke Anklam (European Commission, Belgium)
  • Adam Arkin (University of California, Berkeley, USA)
  • Phil Demokritou (Harvard University, USA)
  • Gerard Escher (École polytechnique fédérale de Lausanne, Switzerland)
  • Lisa Friedersdor (National Nanotechnology Initiative, USA)
  • James Lambert (President, Society for Risk Analysis, USA)
  • Andre Nel (The University of California, Los Angeles, USA)
  • Bernd Nowack (EMPA, Switzerland)
  • Ortwin Renn (University of Stuttgart, Germany)
  • Vicki Stone (Heriot-Watt University, UK)
  • Theo Vermeire (National Institute for Public Health and the Environment (RIVM), Netherlands)
  • Tom van Teunenbroek (Ministry of Infrastructure and Environment, The Netherlands)
  • Wendel Wohlleben (BASF, Germany)

The New Tools and Approaches for Nanomaterial Safety Assessment (NMSA) conference aims at presenting the main results achieved in the course of the organizing projects fostering a discussion about their impact in the nanosafety field and possibilities for future research programmes.  The conference welcomes consortium partners, as well as representatives from other EU projects, industry, government, civil society and media. Accordingly, the conference topics include: Hazard assessment along the life cycle of nano-enabled products, Exposure assessment along the life cycle of nano-enabled products, Risk assessment & management, Systems biology approaches in nanosafety, Categorization & grouping of nanomaterials, Nanosafety infrastructure, Safe by design. The NMSA conference key note speakers include:

  • Harri Alenius (University of Helsinki, Finland,)
  • Antonio Marcomini (Ca’ Foscari University of Venice, Italy)
  • Wendel Wohlleben (BASF, Germany)
  • Danail Hristozov (Ca’ Foscari University of Venice, Italy)
  • Eva Valsami-Jones (University of Birmingham, UK)
  • Socorro Vázquez-Campos (LEITAT Technolоgical Center, Spain)
  • Barry Hardy (Douglas Connect GmbH, Switzerland)
  • Egon Willighagen (Maastricht University, Netherlands)
  • Nina Jeliazkova (IDEAconsult Ltd., Bulgaria)
  • Haralambos Sarimveis (The National Technical University of Athens, Greece)

During the SUN-caLIBRAte Stakeholder workshop the final version of the SUN user-friendly, software-based Decision Support System (SUNDS) for managing the environmental, economic and social impacts of nanotechnologies will be presented and discussed with its end users: industries, regulators and insurance sector representatives. The results from the discussion will be used as a foundation of the development of the caLIBRAte’s Risk Governance framework for assessment and management of human and environmental risks of MN and MN-enabled products.

The SRA Policy Forum: Risk Governance for Key Enabling Technologies and the New Tools and Approaches for Nanomaterial Safety Assessment conference are now open for registration. Abstracts for the SRA Policy Forum can be submitted till 15th November 2016.
For further information go to:

There you have it.

New method for measuring risks and quantities of engineered nanomaterials delivered to cells

Despite all the talk about testing engineered nanoparticles and their possible effects on cells, there are problems with the testing process which researchers at the Harvard School of Public Health (HSPH) claim to have addressed (h/t Nanowerk, March 28, 2014).

A March 28, 2014 HSPH press release explains the interest in testing the effects of engineered nanomaterials/nanoparticles on health and describes some of the problems associated with testing their interaction with cells,

Thousands of consumer products containing engineered nanoparticles — microscopic particles found in everyday items from cosmetics and clothing to building materials — enter the market every year. Concerns about possible environmental health and safety issues of these nano-enabled products continue to grow with scientists struggling to come up with fast, cheap, and easy-to-use cellular screening systems to determine possible hazards of vast libraries of engineered nanomaterials. However, determining how much exposure to engineered nanoparticles could be unsafe for humans requires precise knowledge of the amount (dose) of nanomaterials interacting with cells and tissues such as lungs and skin.

With chemicals, this is easy to do but when it comes to nanoparticles suspended in physiological media, this is not trivial. Engineered nanoparticles in biological media interact with serum proteins and form larger agglomerates which alter both their so called effective density and active surface area and ultimately define their delivery to cell dose and bio-interactions. This behavior has tremendous implications not only in measuring the exact amount of nanomaterials interacting with cells and tissue but also in defining hazard rankings of various engineered nanomaterials (ENMs). As a result, thousands of published cellular screening assays are difficult to interpret and use for risk assessment purposes.

The press release goes on to describe the new technique (Note: Links have been removed),

Scientists at the Center for Nanotechnology and Nanotoxicology at Harvard School of Public Health (HSPH) have discovered a fast, simple, and inexpensive method to measure the effective density of engineered nanoparticles in physiological fluids, thereby making it possible to accurately determine the amount of nanomaterials that come into contact with cells and tissue in culture.

The method, referred to as the Volumetric Centrifugation Method (VCM), was published in the March 28, 2014 Nature Communications.

The new discovery will have a major impact on the hazard assessment of engineered nanoparticles, enabling risk assessors to perform accurate hazard rankings of nanomaterials using cellular systems. Furthermore, by measuring the composition of nanomaterial agglomerates in physiologic fluids, it will allow scientists to design more effective nano-based drug delivery systems for nanomedicine applications.

“The biggest challenge we have in assessing possible health effects associated with nano exposures is deciding when something is hazardous and when it is not, based on the dose level. At low levels, the risks are probably miniscule,” said senior author Philip Demokritou, associate professor of aerosol physics in the Department of Environmental Health at HSPH. “The question is: At what dose level does nano-exposure become problematic? The same question applies to nano-based drugs when we test their efficiency using cellular systems. How much of the administered nano-drug will come in contact with cells and tissue? This will determine the effective dose needed for a given cellular response,” Demokritou said.

Federal regulatory agencies do not require manufacturers to test engineered nanoparticles, if the original form of the bulk material has already been shown to be safe. However, there is evidence that some of these materials could be more harmful in the nanoscale — a scale at which materials may penetrate cells and bypass biological barriers more easily and exhibit unique physical, chemical, and biological properties compared to larger size particles. Nanotoxicologists are struggling to develop fast and cheap toxicological screening cellular assays to cope with the influx of vast forms of engineered nanomaterials and avoid laborious and expensive animal testing. However, this effort has been held back due to the lack of a simple-to-use, fast, method to measure the dose-response relationships and possible toxicological implications. While biological responses are fairly easy to measure, scientists are struggling to develop a fast method to assess the exact amount or dose of nanomaterials coming in contact with cells in biological media.

“Dosimetric considerations are too complicated to consider in nano-bio assessments, but too important to ignore,” Demokritou said. “Comparisons of biological responses to nano-exposures usually rely on guesstimates based on properties measured in the dry powder form (e.g., mass, surface area, and density), without taking into account particle-particle and particle-fluid interactions in biological media. When suspended in fluids, nanoparticles typically form agglomerates that include large amounts of the suspending fluid, and that therefore have effective densities much lower than that of dry material. This greatly influences the particle delivery to cells, and reduces the surface area available for interactions with cells,” said Glen DeLoid, research associate in the Department of Environmental Health, one of the two lead authors of the study. “The VCM method will help nanobiologists and regulators to resolve conflicting in vitro cellular toxicity data that have been reported in the literature for various nanomaterials. These disparities likely result from lack of or inaccurate dosimetric considerations in nano-bio interactions in a cellular screening system,” said Joel Cohen, doctoral student at HSPH and one of the two lead authors of the study.

Here’s a link to and a citation for the paper,

Estimating the effective density of engineered nanomaterials for in vitro dosimetry by Glen DeLoid, Joel M. Cohen, Tom Darrah, Raymond Derk, Liying Rojanasakul, Georgios Pyrgiotakis, Wendel Wohlleben, & Philip Demokritou. Nature Communications 5, Article number: 3514 doi:10.1038/ncomms4514 Published 28 March 2014

This paper is behind a paywall but a free preview is available via ReadCube Access.